Rescuing tri-heteromeric NMDA receptor function: the potential of pregnenolone-sulfate in loss-of-function GRIN2B variants
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Rescuing tri-heteromeric NMDA receptor function: the potential of pregnenolone-sulfate in loss-of-function GRIN2B variants ; volume:81 ; number:1 ; day:25 ; month:5 ; year:2024 ; pages:1-19 ; date:12.2024
Cellular and molecular life sciences ; 81, Heft 1 (25.5.2024), 1-19, 12.2024
- Urheber
-
Kellner, Shai
Berlin, Shai
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00018-024-05243-x
- URN
-
urn:nbn:de:101:1-2408051138423.007137281320
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kellner, Shai
- Berlin, Shai
- SpringerLink (Online service)
Ähnliche Objekte (12)
Loss-of-function uORF mutations in human malignancies
Characterization of a new mouse p53 variant: loss-of-function and gain-of-function
Evaluating drug targets through human loss-of-function genetic variation
Loss-of-function phenotype of a PKCθT219A knockin mouse strain
Broad network-based predictability of Saccharomyces cerevisiaegene loss-of-function phenotypes
Loss-of-function genetic diseases and the concept of pharmaceutical targets
Loss-of-function of leptin receptor impairs metabolism in human cardiomyocytes
Adaptive selection drives TRPP3 loss-of-function in an Ethiopian population
Loss-of-function, gain-of-function and dominant-negative mutations have profoundly different effects on protein structure
Investigation into the Health Effects of Reduced Chymase Function Using Predicted Loss-of-Function Mutations in CMA1
Heterozygous loss-of-function variants in DOCK4 cause neurodevelopmental delay and microcephaly
Genome-wide loss-of-function analysis of deubiquitylating enzymes for zebrafish development
Loss-of-function uORF mutations in human malignancies
Characterization of a new mouse p53 variant: loss-of-function and gain-of-function
Evaluating drug targets through human loss-of-function genetic variation
Loss-of-function phenotype of a PKCθT219A knockin mouse strain
Broad network-based predictability of Saccharomyces cerevisiaegene loss-of-function phenotypes
Loss-of-function genetic diseases and the concept of pharmaceutical targets
Loss-of-function of leptin receptor impairs metabolism in human cardiomyocytes
Adaptive selection drives TRPP3 loss-of-function in an Ethiopian population
Loss-of-function, gain-of-function and dominant-negative mutations have profoundly different effects on protein structure
Investigation into the Health Effects of Reduced Chymase Function Using Predicted Loss-of-Function Mutations in CMA1
Heterozygous loss-of-function variants in DOCK4 cause neurodevelopmental delay and microcephaly
Genome-wide loss-of-function analysis of deubiquitylating enzymes for zebrafish development
Loss-of-function uORF mutations in human malignancies
Characterization of a new mouse p53 variant: loss-of-function and gain-of-function
Evaluating drug targets through human loss-of-function genetic variation
Loss-of-function phenotype of a PKCθT219A knockin mouse strain
Broad network-based predictability of Saccharomyces cerevisiaegene loss-of-function phenotypes
Loss-of-function genetic diseases and the concept of pharmaceutical targets
Loss-of-function of leptin receptor impairs metabolism in human cardiomyocytes
Adaptive selection drives TRPP3 loss-of-function in an Ethiopian population
Loss-of-function, gain-of-function and dominant-negative mutations have profoundly different effects on protein structure
Investigation into the Health Effects of Reduced Chymase Function Using Predicted Loss-of-Function Mutations in CMA1
Heterozygous loss-of-function variants in DOCK4 cause neurodevelopmental delay and microcephaly